We present a further evaluation of an improved recording method for the acoustic detection of intracranial aneurysms (ADA). A sensor was applied to the patient's eyes. Two measures were derived to summarize the power spectral density functions of the sound frequencies that were obtained from each patient: the power median (PM), the median of the power spectral density function, and the mean difference error (MDE), a measure of the difference between the normalized, logarithmically transformed spectra of the patient and a template, the normal spectrum. The capability of these two measures (alone or combined) to discriminate between patients with and without an intracranial aneurysm was tested in a series of 89 patients harbouring a total of 109 aneurysms and 73 controls, using multiple logistic regression analysis. When PM and MDE were combined, the accuracy of the predictions amounted to 79%. Individualized threshold values of the likelihood ratio of harbouring an aneurysm, for ordering four-vessel angiography are suggested, depending on the prior probability of harbouring an aneurysro, the risks of unnecessary angiography and the risk of living with an undetected aneurysm. Our decision analysis suggests that using these recommendations, employing acoustic detection results in a small gain in quality adjusted life expectancy (0.01 life year) for patients aged between 40 and 60, compared to no diagnostic testing, and 0.02 life year compared to angiography, which cannot be recommended. For patients with a three times increased prior risk of harbouring an intracranial aneurysm, the benefit of ADA compared to angiography increases to 0.05 life year. We conclude that acoustic detection has the potential of becoming a useful tool in the non-invasive diagnosis of occult, asymptomatic intracranial aneurysms.
Introduction
Aneurysmal subarachnoid haemorrhage (SAH) occurs at a population rate of 1/10,000 annually, with a mortality of more than 50% [2, 11, 23] . Unruptured intracranial aneurysms are present in at least one percent of the general population, and they constitute a major risk to health [18, 38, 39] . Screening for unruptured intracranial aneurysms has been advocated or carried out in high risk groups, such as relatives of patients with SAH [4] and patients with autosomal dominant polycystic kidney disease [5, 37] . However, a convenient diagnostic procedure is not yet available for routine clinical use.
Angiography has a risk of complications and is expensive and time-consuming, because it is usually an in-hospital investigation. Not only should a screening strategy preferably be non-invasive, but it should also be reliable and accurate. High resolution CT scanning lacks sensitivity for smaller aneurysms [19, 27, 30] , magnetic resonance imaging and magnetic resonance angiography have not yet been evaluated properly [3, 21, 26] , and both are expensive procedures.
It has long been known that aneurysms emit sounds, although early reports may actually have concerned bruits caused by vasospasm in patients with a ruptured aneurysm [25] . Later studies which made use of electronic stethoscopes suggested that the aneurysm itself generates vibration, probably because of turbulence of the aneurysmal blood flow. However, the sensitivity of such procedures seemed to be low, i.e., less than 50% [16, 17, 20, 28, 29] . We present further results of the evaluation of an improved acoustic detection technique for intracranial aneurysms (ADA). We evaluated its diagnostic accuracy and analysed the clinical indications for its use with decision theory, taking into account the benefits of treatment of an unruptured aneurysm, and the risk of angiography and aneurysm surgery.
Methods and Patients

Patients
Eighty-nine patients with a total of 104 aneurysms who were consecutively admitted to the neurosurgical department of the Groningen University Hospital with aneurysmal subarachnoid haemorrhage (n = 77), or with an unruptured aneurysm (n = 12) were evaluated with the acoustic detection technique. All aneurysms were confirmed by angiography. The control group consisted of 73 patients without known intracranial pathology; they were admitted to the clinic for spinal abnormalities: disc protrusion, spinal stenosis or carpal tunnel syndrome. The results on the first 26 controls and aneurysm patients have been published earlier [31] , and another sample of these patients was used as controls in a study of patients with brain tumours [33] .
Acoustic Detection of Aneurysms
Our procedure for the recording of intracranial sound has been described earlier [15, 31] . Briefly, microphones were placed over the closed eyes of each patient, using ultrasonic transmission geI (Fig, 1) . The sound signals from the microphones were amplified and filtered (band pass 200-1250 Hz, 2nd order), and sent to a personal computer. An electrocardiogram signal was recorded simultaneously to obtain a trigger signal. A delay of 200 ms between trigger and sampling procedure was chosen, because the maximum_ blood-flow velocity, and therefore, the maximum sound amplitude in the intracranial vessels occurs between 200 and 300 ms after the R-wave of the QRS-complex. With a real-time Fast Fourier Transform procedure the time series were transformed into power periodograms. Approximately 50 periodograms were obtained and averaged. The resulting power spectra (relative power spectral density as a function of the frequency), were shown from 200-1250 Hz, and normalized to their maximum value. An automatic clipping technique was used for selectively removing loud signals such as from breathing, eye blinking or movement. One measuring cycle, consisting of sampling, FFT and averaging had a duration of 850 msec; the total diagnostic procedure took 10-15 minutes.
Two measures were used to summarize the power spectral density functions of the sound frequencies that were obtained from each patient. The first, the power median (PM), is the median of the power spectral density function: the frequency at which the area below the power spectrum on the left equals the area below the power spectrum on the right. The choice of this parameter was based on the observation in previous experiments that the medians of the spectra in normal patients were rather shifted to the left, whereas every disturbance of the smoothly descending curve results in a shift of the right. To obtain one parameter per measurement, the medians of the power spectra of the left and right eye were simply added. The second measure, the mean difference error (MDE), is a measure of the difference between two normalized, logarithmically transformed spectra: the patient's spectrum and a template, the normal spectrum. This normal spectrum was derived by averaging 9 spectra from independent control subjects, who were not included in the present study. To obtain one parameter per measurement, we took the mean of the MDE of the right and left eye.
Statistical Analysis
We used multiple logistic regression analysis to determine the discriminatory ability of the PM and MDE, alone and combined. In logistic regression analysis, the post-test odds Op of an aneurysm are expressed as:
where each term consists of the product of a regression coefficient [5 and a parameter v (for example the PM or the MDE). * For ease of interpretation, we used base 2 logarithms (loga). Each point increase of the log2 odds doubles the posterior odds. ** Logistic * Odds are defined as O = p/(l-p), where p stands for probability. In particular, odds of 1 correspond to a probability of 50%. In order to go back from odds to probability, once calculates The models were evaluated using a log-likelihood ratio test and the crude error rate, i.e., the rate of patients that were misclassified [121.
Decision Analysis
A simple decision rule would advise action as if an aneurysm would be present when the post-test odds of an aneurysm would be larger than 1, and act as if an aneurysm would not be present when the post-test odds of an aneurysm would be smaller than 1. These are called the diagnostic threshold odds.
The likelihood ratio, which represents the diagnostic information obtaimed from the results of acoustic detection, is computed by taking the ratio of the post-test odds Op and the prior odds Oi:
The lower the prior odds, the higher the LR must be to let the post-test odds meet the threshold odds. The likelihood ratio that, for a certain prior, leads to a certain threshold odds, is called the threshold likelihood ratio (TLR). We adjusted the TLR to the clinical situation (population prevalence) using age-adjusted prior odds of an intracranial aneurysm. The diagnostic threshold likelihood ratio should also be adjusted for the risk/benefit ratio of acoustic detection. When the benefit from surgically treating an aneurysmpatient is much higher than the loss from undergoing "unnecessary" angiography in a patient without an aneurysm, one would be inclined to choose a lower diagnostic threshold, in order to maximize the benefit from aneurysm detection. The lower the loss incurred by angiography compared to the benefit of aneurysm surgery, the lower the threshold likelihood ratio for an aneurysm might be at which angiography may be ordered, and the other way around.
The expected loss from "unnecessary" angiography was expressed in quality adjusted life years, and depended on the [32] Utility of disability 0.75 0.625-0.875 Annual discount rate 5% 0%-10% mortality from angiography, the risk of permanent morbidity and the value of living with permanent neurological disability, the risk of transient morbidity and the time spent with transient morbidity in days, and the time loss from angiography itself, as a function of the normal life expectancy. The benefit of treating a patient with an aneurysm, who was correctly classified (by angiography) as harbouring an aneurysm, was determined by the difference ~ in expected utility between no surgical treatment EU (WAIT) and surgical treatment EU (SUR-GERY). This quantity has to be multiplied by the probability that angiography indeed would have shown the aneurysm, the sensitivity of angiography Se. (Angiography needs to be done in any patient considered to harbour an aneurysm, in order to locate the aneurysm and determine the neurosurgical technique and the test characteristics of angiography are assumed to be independend to those of ADA.)
z~ = [EU(SURGERY)-EU(WAIT) XSe.
These expected utilities were again expressed in (discounted) quality adjusted life years, and they were determined by decision tree analysis. Figure 2 shows the decision tree. It is adapted from previous decision-analytic studies of screening for and therapeutic management of unruptured (familial) intracranial aneurysms [6, 32] . In the decision tree each strategy is described in an orderly way. Time flows from left to right. A square node represents the point in time where a decision must be made. Chance nodes (circles) represent events that cannot be influenced directly by the decision marker. Outcome nodes (rectangles) represent the health states that result from each chain of events and decisions. In NO TEST the aneurysm (if present) may rupture and cause SAH resulting in death, serious permanent neurological disability, or recovery. Compared to the calculations in the acutal analysis, the time aspect has been simplified in the decision tree representation. Subarachnoid haemorrhage, which may occur at any time in the future, has been collapsed into one branch. It is assumed that after a nonfatal SAH the aneurysm is clipped, completely preventing haemorrhage.
When angiography is uneventful and the presence of an intracranial aneurysm is confirmed, surgery may follow. Neurosurgical treatment may be uncomplicated and the patient will lead a normal life, without risk of SAH. Surgery may also lead to serious, permanent neurological disability, or even death. The probabilities and utilities have been estimated and described before [6] (Table l) . Outcomes are expressed in discounted quality adjusted life expectancy [6, 8] . ADA may indicate the presence of an aneurysm, and the same sequence of events will follow as in the case when angio~aphy was ordered directly. When ADA does not indicate an aneurysm, no specific action is assumed to follow.
Results
Highly significant differences in mean difference error (MDE) and power median (PM) were found between cases and controls ( Table 2) . A scatterplot (Fig. 3) suggested that combining the information of the two measurements might enhance the diagnostic performance of ADA, because patients with high values for both PM and MDE seem to be at high risk of harbouring an aneurysm. Three linear logistic regression models were fitted to these data. These three models were all highly significant and did not differ much in discriminatory ability: 39, 38 and 40 patients out of 162 were misclassified ( Table 3 ). The dispersion of the data in Fig. 3 suggested a quadratic relation between the likelihood of harbouring an aneurysm and the PM and the MDE. The fourth quadratic model of Table 3 indeed performed better than the previous thress (34 patients misclassified, for an overall accuracy of 79%). The fit of each model was determined by ordering the patients according to the predicted probability of harbouring an aneurysm, then dividing the patients in 4 equally sized groups, and comparing the expected number of aneurysms according to the model, and the observed number of aneurysm in the data (Table 3 ). Model IV als had the best fit. Each solid line in Fig. 3 divides the cases in those who have a more than 50% (Op>l) chance of harbouring an aneurysm and those who do not, according PM (xl00) Fig. 3 . Results of acoustic detection of aneurysms. X-axis; powermedian (PM), Y-axis: mean difference error (MDE). Filled circles: controls (n = 73), asterisks: (cases n = 89) and results of the logistic regression analyses: unadjusted diagnostic threshold likelihood ratios according to four logistic regression models (see Table 3 ). The lines represent unadjusted diagnostic threshold likelihood ratios that lead to post test odds for an intracranial aneurysm of 1, according the four logistic regression models (I-IV)
to the regression models. However, as we argued in the methods section, this threshold may not be adequate for the application of ADA in clinical practice. Adjustment factors for the diagnostic threshold likelihood ratio are therefore suggested in Table 4 , taking into account the population-based (age-dependent) prior odds of an intracranial aneurysm and the (agedependent) risk-benefit ratio related to angiography and surgical treatment. For patients in the age category between 41 and 60, these two factors almost balance each other. This table lists the benefits or losses incurred when using the acoustic detection in patients without increased risk of harbouring an intracranial aneurysm. Angiography would lead to a small loss, and ADA would lead on average to a small benefit in patients aged less than 70, especially in those aged between 41 and 60.
Discussion
We evaluated an acoustic detection technique to be used in screening for unruptured intracranial aneurysms in a controlled study. Logistic regression analysis was used to determine the diagnostic accuracy and decision theory to establish indications for the use of acoustic detection in clinical practice.
Our results can be used in deciding whether the results of ADA in a certain patient warrant four-vessel cerebral angiography. For example, when a healthy 45-year-old man underwent screening with ADA, the power median might be 700, and the mean PM (xl00) Fig. 4 . Age-dependent threshold likelihood ratios of an intracranial aneurysm after the acoustic detection procedure, as a function of the mean difference error MDE (X-axis) and the power median PM (Y-axis). Above the lines and to the right, angiography is recommended, and below and to the left, no angiography difference error 550, leading to a likelihood ratio of 1, which does not exceed the threshold for ordering angiography (see Fig. 4 ). Therefore, these results would not justify recommending angiography to this patient. The situation would be different when PM would have been 800 and the MDE 500 in this patient. With such a test result, angiography would surely be warranted. When the patient would have an increased risk of harbouring an intracranial aneurysm, for example because he had a first degree family member with SAH, this would lead to an approximate threefold increase in prior odds of harbouring an IA [4] . The TLR could then be adjusted downward to 1/3 of its original value, and angiography should be recommended, according to this analysis. If the patient had been 75 years old, then aneurysm surgery could never be recommended because the risk/benefit ratio would be negative and angiography should not be performed (Table 4) . Table 5 shows that the population prevalence is lower than the probability that is minimally needed to justify angiography: the difference in expected utility between no testing and angiography is always negative, i.e., in favour of no testing. On average, a tiny amount of quality adjusted life expectancy will be gained by ADA, especially in the age group of 40-60. Listed are the prior probability of an intracranial aneurysm as a function of age, the probability of being detected and operated on, and the difference in quality adjusted life expectancy between angiography and no testing (6EU1) and between ADA and no testing (6EU2).
This provides the rationale for detection of aneurysms with a non-invasive, riskless device such as ADA, in order to select patients for angiography. In our study, control patients did not undergo angiography. Thus, it cannot be excluded that one or more control patients actually harboured an intracranial aneurysm. This is not such a great problem, because the prevalence of aneurysms in asymptomatic patients is just a few percent. The alternative would have been to let all control patients undergo angiography, thereby exposing them to unnecessary risks. Perhaps a future study confined to patients at high risk of harbouring an IA, angiography may be carried out prospectively, and independently to acoustic detection. Most cases were patients with ruptured aneurysms, who were studied before they were operated on. Rupture of the aneurysm, but also vasospasm may have changed the spectrum of intracranial sounds. Vasospasm was excluded by repeated transcranial doppler studies in our patients. The observer was not blind to the diagnosis, because of practical circumstances, However, as we used an objective measurement, the results could scarcely have been influenced by knowledge of the actual diagnosis. On the other hand, we did not consider the possibility that abnormal test results may also point at intracranial pathology other than aneurysms, such as meningiomas or other brain tumours, arteriovenous malformations, etc. In clinical practice, a false-positive result may thus have unexpected consequences, and perhaps even be advantageous to the patient.
MR-angiography seems to be developing into the preferred non-invasive detection procedure for intracranial aneurysms. MR-angiography is more expensive than ADA. Moreover, its sensitivity may be impaired because of superimposition of vessels (venous and arterial), a technical problem that is not yet solved. Clinicians and health care managers alike should not rest content with the fact that this technique has not yet been formally evaluated with regard to diagnostic accuracy and costs for detection of intracranial aneurysms.
The results of any decision analysis, particularly of the present one, should be considered as a recommendation, which is blinded to the details of the clinical situation. The judgment whether the recommendation should be followed depends on the treating physician. The management of the patient always remains the responsibility of the doctor, it is he or she who gathers and judges the clinical information and weighs the evidence. Perhaps the decision model should best be integrated with the software for sampling the sound frequencies in the acoustic detection device, so that the management recommendation could be produced alongside with the power spectral density functions and its derived measures, the PM and MDE.
To obtain reasonable certainty that ADA really is worthwhile from a clinical point of view, an independent study should be able to reproduce the results we presented here, and costs should also be taken into account. Such a study, in which MR angiography is also evaluated, is currently being carried out. The results of the present study suggest that acoustic detection has the potential of becoming a useful tool in the non-invasive diagnosis of occult, asymptomatic intracranial aneurysms. The authors describe a method for acoustic detection of intracranial aneurysms with microphones applied to the patient's eyes. The accuracy of prediction of an intracranial aneurysm was 79%. They conclude that this method could be a useful tool for the noninvasive diagnosis of occult, asymptomatic intracranial aneurysms.
It would be interesting in a future study to combine the acoustic method with MR-angiography even though more expensive, but also a non-invasive method for comparison of the acurracy of the prediction of an asymptomatic aneurysm. Maybe MR-angiography would be a second method after acoustic investigation in patients with doubtful results by the first method.
